Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
C2 domain containing 3 centriole elongation regulator (C2CD3) encodes a centriolar protein essential for the elongation and maturation of centrioles within cells, particularly through the assembly of centriolar distal appendages and recruitment of ciliogenic proteins needed for cilium formation. C2CD3 contains both classical (PKC-like) and non-classical C2 domains, which facilitate membrane targeting, vesicle docking, and possibly microtubule stabilization. It is evolutionarily conserved and localizes to the distal ends of both mother and daughter centrioles. Loss of function, due to mutation, results in defective cilium formation and signaling—especially affecting Hedgehog pathway signaling—and underpins the pathogenesis of ciliopathies such as oral-facial-digital syndrome type XIV. These disorders lead to craniofacial, oral, and limb malformations due to impaired cilium-dependent cell signaling and tissue morphogenesis[1][2][3][4].
C2CD3 is not a recognized pharmacological target; there are no drugs with defined mechanisms of action on this protein.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on C2 domain containing 3 centriole elongation regulator (C2CD3).